Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.

Ogari CO, Nyamache AK, Nonoh J, Amukoye E.

BMC Infect Dis. 2019 Mar 25;19(1):279. doi: 10.1186/s12879-019-3911-9.

2.

Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).

Dawa J, Chaves SS, Ba Nguz A, Kalani R, Anyango E, Mutie D, Muthoka P, Tabu C, Maritim M, Amukoye E, Were F; Kenya National Immunization Technical Advisory Group (KENITAG).

Vaccine. 2019 Jan 14;37(3):464-472. doi: 10.1016/j.vaccine.2018.11.062. Epub 2018 Nov 27.

3.

Biosafety and biosecurity capacity building: insights from implementation of the NUITM-KEMRI biosafety training model.

Muriithi B, Bundi M, Galata A, Miringu G, Wandera E, Kathiiko C, Odoyo E, Kamemba M, Amukoye E, Huqa S, Shah M, Inoue S, Ichinose Y.

Trop Med Health. 2018 Aug 8;46:30. doi: 10.1186/s41182-018-0108-7. eCollection 2018.

4.

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.

Tweed CD, Crook AM, Amukoye EI, Dawson R, Diacon AH, Hanekom M, McHugh TD, Mendel CM, Meredith SK, Murphy ME, Murthy SE, Nunn AJ, Phillips PPJ, Singh KP, Spigelman M, Wills GH, Gillespie SH.

BMC Infect Dis. 2018 Jul 11;18(1):317. doi: 10.1186/s12879-018-3230-6.

5.

Exposure reductions associated with introduction of solar lamps to kerosene lamp-using households in Busia County, Kenya.

Lam NL, Muhwezi G, Isabirye F, Harrison K, Ruiz-Mercado I, Amukoye E, Mokaya T, Wambua M, Bates MN.

Indoor Air. 2018 Mar;28(2):218-227. doi: 10.1111/ina.12433. Epub 2017 Oct 31.

PMID:
29028275
6.

Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis.

Olliaro PL, Merle C, Mthiyane T, Bah B, Kassa F, Amukoye E, N Diaye A, Perronne C, Lienhardt C, McIlleron H, Fielding K.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e01834-16. doi: 10.1128/AAC.01834-16. Print 2017 Jul.

7.
8.

A four-month gatifloxacin-containing regimen for treating tuberculosis.

Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, Odhiambo J, Amukoye E, Bah B, Kassa F, N'Diaye A, Rustomjee R, de Jong BC, Horton J, Perronne C, Sismanidis C, Lapujade O, Olliaro PL, Lienhardt C; OFLOTUB/Gatifloxacin for Tuberculosis Project.

N Engl J Med. 2014 Oct 23;371(17):1588-98. doi: 10.1056/NEJMoa1315817. Erratum in: N Engl J Med. 2015 Apr 23;372(17):1677.

9.

Mycobacterium tuberculosis-specific CD8+ T cell recall in convalescing TB subjects with HIV co-infection.

Ongaya A, Huante MB, Mwangi P, Keiser PH, Amukoye E, Endsley JJ.

Tuberculosis (Edinb). 2013 Dec;93 Suppl:S60-5. doi: 10.1016/S1472-9792(13)70012-X.

PMID:
24388651
10.

ASSOCIATION BETWEEN FINGER CLUBBING AND CHRONIC LUNG DISEASE IN HIV INFECTED CHILDREN AT KENYATTA NATIONAL HOSPITAL.

Odionyi JJ, Yuko-JOWL CA, Wamalwa D, Bwibo N, Amukoye E.

East Afr Med J. 2013 Nov;90(11):342-9.

PMID:
26862635
11.

Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya.

Abuogi LL, Mwachari C, Leslie HH, Shade SB, Otieno J, Yienya N, Sanguli L, Amukoye E, Cohen CR.

Int J Tuberc Lung Dis. 2013 Oct;17(10):1291-7. doi: 10.5588/ijtld.12.0740.

12.

Risk factors of severe pneumonia among children aged 2-59 months in western Kenya: a case control study.

Onyango D, Kikuvi G, Amukoye E, Omolo J.

Pan Afr Med J. 2012;13:45. Epub 2012 Nov 1.

13.

Impact of smear microscopy results and observed therapy on tuberculosis treatment in Mombasa, Kenya.

Arentz M, Narita M, Sangaré L, Kah JF, Low D, Mandaliya K, Amukoye E, Sitienei J, Walson JL.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1656-63. doi: 10.5588/ijtld.10.0625.

PMID:
22118174
14.

Activation of NK cell granulysin by mycobacteria and IL-15 is differentially affected by HIV.

Hogg A, Huante M, Ongaya A, Williams J, Ferguson M, Cloyd M, Amukoye E, Endsley J.

Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S75-81. doi: 10.1016/j.tube.2011.10.015. Epub 2011 Nov 17.

PMID:
22099421
15.

Oxacillin resistant Staphylococcus aureus among HIV infected and non-infected Kenyan patients.

Ouko TT, Ngeranwa JN, Orinda GO, Bii CC, Amukoye E, Lucy M, Wamae CN.

East Afr Med J. 2010 May;87(5):179-86.

PMID:
23057279
16.

Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya.

Bulimo WD, Garner JL, Schnabel DC, Bedno SA, Njenga MK, Ochieng WO, Amukoye E, Magana JM, Simwa JM, Ofula VO, Lifumo SM, Wangui J, Breiman RF, Martin SK.

Influenza Other Respir Viruses. 2008 May;2(3):107-13. doi: 10.1111/j.1750-2659.2008.00044.x.

17.

Chlorproguanil - Dapsone a new drug in the fight against malaria.

Amukoye EI.

Afr J Health Sci. 2004;11(1-2):1-8. No abstract available.

PMID:
17298112
18.

Pneumocystis jirovecii and microbiological findings in children with severe pneumonia in Nairobi, Kenya.

Bii CC, Kose J, Taguchi H, Amukoye E, Ouko TT, Muita LC, Mugasia O, Wamae N, Kamiya S.

Int J Tuberc Lung Dis. 2006 Nov;10(11):1286-91.

PMID:
17131790
19.

Prevalence and risk factors of smoking among secondary school students in Nairobi.

Kwamanga DH, Odhiambo JA, Amukoye EI.

East Afr Med J. 2003 Apr;80(4):207-12.

PMID:
12918805
20.

Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya.

Chakaya JM, Bii C, Ng'ang'a L, Amukoye E, Ouko T, Muita L, Gathua S, Gitau J, Odongo I, Kabanga JM, Nagai K, Suzumura S, Sugiura Y.

East Afr Med J. 2003 Jan;80(1):30-5.

PMID:
12755239
21.

Antifungal drug susceptibility of Candida albicans.

Bii CC, Ouko TT, Amukoye E, Githinji LW.

East Afr Med J. 2002 Mar;79(3):143-5.

PMID:
12389961
22.

Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

Amukoye E, Winstanley PA, Watkins WM, Snow RW, Hatcher J, Mosobo M, Ngumbao E, Lowe B, Ton M, Minyiri G, Marsh K.

Antimicrob Agents Chemother. 1997 Oct;41(10):2261-4.

23.

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.

Winstanley P, Watkins W, Muhia D, Szwandt S, Amukoye E, Marsh K.

Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):322-7.

PMID:
9231209
24.

Deep breathing in children with severe malaria: indicator of metabolic acidosis and poor outcome.

English M, Waruiru C, Amukoye E, Murphy S, Crawley J, Mwangi I, Peshu N, Marsh K.

Am J Trop Med Hyg. 1996 Nov;55(5):521-4.

PMID:
8940984
25.

Chronic salicylate poisoning and severe malaria.

English M, Marsh V, Amukoye E, Lowe B, Murphy S, Marsh K.

Lancet. 1996 Jun 22;347(9017):1736-7.

PMID:
8656907
26.

An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children.

Murphy S, English M, Waruiru C, Mwangi I, Amukoye E, Crawley J, Newton C, Winstanley P, Peshu N, Marsh K.

Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):298-301.

PMID:
8758084
27.

The management of severe malaria in children: a review.

Murphy S, English M, Omar A, Crawley J, Waruiru C, Mwangi I, Amukoye E, Peshu N, Newton CR, Winstanley PA, et al.

East Afr Med J. 1995 Aug;72(8):536-9. Review.

PMID:
7588152

Supplemental Content

Loading ...
Support Center